Plain-English translation of NCT06737588 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Researchers are studying whether a special type of MRI scan — combined with measurements called Apparent Diffusion Coefficients (ADC) — can help doctors more accurately detect prostate cancer. The study enrolls about 600 people who have already had an MRI showing possible signs of cancer and are scheduled for a biopsy. By comparing these new measurements to your biopsy results, the research team hopes to learn whether this approach could improve how doctors diagnose prostate cancer.
Current MRI methods are helpful but not perfect at spotting prostate cancer. This study aims to see whether adding these special measurements could make the diagnosis more accurate, potentially sparing some men from unnecessary biopsies or catching cancer earlier in others.
You likely qualify if…
You likely don't qualify if…
You will have already completed an MRI scan of your prostate. Before your biopsy, the research team will collect information about your age, weight, PSA levels, and other measurements from your MRI. Then you will undergo a standard prostate biopsy — either the routine kind or one guided by the MRI images — depending on what your doctor recommends. After the biopsy, a pathologist will examine the tissue sample. The researchers will use all this information to determine whether the new MRI measurements help predict cancer more accurately than current methods.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China